添加微信 添加微信
添加微信
首页: 全球医药政策

丹麦-Pharmacosmos

时间:2021-10-21 13:47:54 来源:康安医药咨询 作者:康安医药咨询

Pharmacosmos was established in 1965 by Henry Christensen MD, PhD, who was succeeded by his youngest son Lars Christensen, MD, as CEO in 1993. The company has since its establishment remained an independent family owned company. The first 500 m2 manufacturing site - site Viby - was established in 1965 in a former dairy in a small village about 40 kilometres from the current site Holbaek. The original manufacturing site was expanded to approximately 1800 m2 in 1973. Originally, the company was an API manufacturer of dextran powder of clinical grade, pharmacopoeial quality for production of infusion solutions and iron complexes. The API was and is still available in powder and/or bulk solutions for the manufacturing of veterinary iron dextran injection. The company gained GMP approval from Danish Ministry of Health early-on, followed by a number of US FDA approvals after a 1983 US FDA inspection carried out by Mr Charles A. Wayne.

Phone: 4559485959 Fax: 4559485960 E-mail: info@pharmacosmos.com
Web: https://www.pharmacosmos.com
Add:Pharmacosmos A/S ,Roervangsvej 30 ,DK-4300 Holbaek

想要下载更多资料,请您添加微信了解详情!

微信号:csco2022

公众号:康安医药咨询

当前栏目

频道栏目

最新文章

热门文章